NeuroOne Medical Technologies Corporation logo

NeuroOne Medical Technologies Corporation (NMTC) Q1 2026 Earnings

NMTC·Reported May 12, 2026·Before market open

NeuroOne Medical Technologies Corporation reported Q1 2026 revenue of $2.4M (+72.5% YoY), missed analyst consensus of $2.6M by $186.6K. Diluted EPS came in at $-0.25 (-257.1% YoY), missed the $-0.23 consensus by $0.02.

Revenue
$2.4Mmissed by $186.6K
Consensus: $2.6M
Diluted EPS
$-0.25missed by $0.02
Consensus: $-0.23
SEC

SEC Filings

Earnings release8-K · 0001213900-26-054744
Quarterly report10-Q · 0001213900-26-054749

Financial Snapshot

Trailing eight quarters through Q1 2026

View all metrics

Q1 2026 Earnings FAQ

Common questions about NeuroOne Medical Technologies Corporation's Q1 2026 earnings report.

NeuroOne Medical Technologies Corporation (NMTC) reported Q1 2026 earnings on May 12, 2026 before market open.

NeuroOne Medical Technologies Corporation reported revenue of $2.4M and diluted EPS of $-0.25 for Q1 2026.

Revenue missed the consensus estimate of $2.6M by $186.6K. EPS missed the consensus estimate of $-0.23 by $0.02.

Compared to the same quarter a year prior, revenue grew 72.5% from $1.4M a year earlier and diluted EPS declined 257.1% from $-0.07.

You can read the 8-K earnings release (0001213900-26-054744) and the 10-Q periodic report (0001213900-26-054749) directly on SEC EDGAR. The filing index links above go to sec.gov.